Stockreport

IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock? [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF to softer sales of its sole marketed product, Linzess (linaclotide), during the fourth quarter of 2025. The stock has plunged 14.2% over the past month, while the indust [Read more]